|
|
|
 |
|
|
| Viral transfer technology |
|
| Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells FREE |
| D Nègre, P-E Mangeot, G Duisit, S Blanchard, P-O Vidalain, P Leissner, A-J Winter, C Rabourdin-Combe, M Mehtali, P Moullier, J-L Darlix & F-L Cosset |
| Abstract | Full text | PDF |
|
| 1613 |
|
| Viral transfer technology |
|
| Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo FREE |
| C Gaetano, A Catalano, R Palumbo, B Illi, G Orlando, G Ventoruzzo, F Serino & M C Capogrossi |
| Abstract | Full text | PDF |
|
| 1624 |
|
| Inherited disease |
|
| Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: implications for gene therapy FREE |
| E Sat, K H Leung, L Bruckner-Tuderman & K S E Cheah |
| Abstract | Full text | PDF |
|
| 1631 |
|
| Acquired diseases |
|
| Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element FREE |
| P Jaakkola, M Ahonen, V-M Kähäri & M Jalkanen |
| Abstract | Full text | PDF |
|
| 1640 |
|
| Quantitation of HSV mass distribution in a rodent brain tumor model FREE |
| D Schellingerhout, N G Rainov, X O Breakefield & R Weissleder |
| Abstract | Full text | PDF |
|
| 1648 |
|
| A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy FREE |
| R M Diaz, A Bateman, L Emiliusen, A Fielding, D Trono, S J Russell & R G Vile |
| Abstract | Full text | PDF |
|
| 1656 |
|
| In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model FREE |
| K Hayashi, S Nakamura, R Morishita, A Moriguchi, M Aoki, K Matsumoto, T Nakamura, Y Kaneda, N Sakai & T Ogihara |
| Abstract | Full text | PDF |
|
| 1664 |
|
| Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity FREE |
| D W Ju, Y Yang, Q Tao, W G Song, L He, G Chen, S Gu, C C Ting & X Cao |
| Abstract | Full text | PDF |
|
| 1672 |
|
| Cell-based therapy |
|
| Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity FREE |
| M Brown, Y Zhang, S Dermine, E A de Wynter, C Hart, H Kitchener, P L Stern, M A Skinner & S N Stacey |
| Abstract | Full text | PDF |
|
| 1680 |
|
| Nonviral transfer technology |
|
| Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines FREE |
| C-K Chan, T Senden & D A Jans |
| Abstract | Full text | PDF |
|
| 1690 |
|
| Nonviral transfer technology |
|
| Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes FREE |
| Q-R Chen, L Zhang, S A Stass & A J Mixson |
| Abstract | Full text | PDF |
|
| 1698 |
|
| Correspondence |
|
| Comment on the use of the cre/loxP recombinase system for gene therapy vectors FREE |
| S D Scott & B Marples |
| Abstract | Full text | PDF |
|
| 1706 |
|
|
|
| October 2000, Volume 7, Number 19 |
|
| <Previous Issue Next > |
